Your Google Ads dashboard can show a Healthcare / Pharma campaign hitting its CPA target without ever revealing how many of those clicks and conversions came from a real patient, caregiver, or HCP rather than a bot that already cleared Google's own filters. Lunio built the benchmarks on this page from an independent detection layer monitoring live Google Ads accounts, which is why it includes invalid traffic rates that no other Healthcare / Pharma benchmark report publishes. Find out how much of your Google Ads budget is being wasted →
Google Ads Benchmarks for Healthcare / Pharma at a Glance
- Average CPC: Healthcare / Pharma advertisers running Search on Google Ads pay an average of $6.775 per click, per Lunio's 2026 Healthcare / Pharma benchmark dataset covering tracked accounts as of September 2026. That sits well above the $5.64 overall healthcare search CPC that LocaliQ reported across 3,542 US campaigns between October 2024 and September 2025, which likely reflects a sample weighted toward large-spend advertisers bidding on high-intent pharma and clinical terms rather than small local practices.
- CPM & CTR: No healthcare-specific CPM benchmark exists for Google Ads from any verifiable source, a gap every ranking benchmark page shares. On CTR, LocaliQ's analysis of healthcare search campaigns over the same October 2024 to September 2025 period puts average CTR at 6.07%, nearly double the 3.27% figure that WordStream reported from its 2017 to 2018 sample and that still circulates across most agency blogs today without that age disclosed.
- Invalid traffic rate: Lunio's 2026 Healthcare / Pharma dataset puts Search IVT at 4.39% across tracked accounts, traffic that cleared Google's own filtration and was still flagged as invalid by an independent detection engine. Display carries the highest campaign-type rate in the dataset at 6.04%.
- Your hidden cost: At a $6.775 average Search CPC and 4.39% IVT, roughly $0.30 of every Search click's budget never reaches a real patient or HCP, before accounting for how those invalid clicks quietly retrain Smart Bidding over time. Lunio runs a free 14-day traffic audit that shows exactly how much of your own account's spend is affected. Calculate how much you're losing →
Google Ads Benchmarks for Healthcare / Pharma: Overall Metrics
Healthcare / Pharma is one of the most structurally expensive verticals on Google Ads. Patient lifetime value of $10,000 to $20,000 per relationship, per Promodo's 2026 healthcare marketing benchmarks, supports aggressive bidding, while Google's Healthcare and Medicines advertising policy restricts remarketing and condition-based targeting, compressing the pool of eligible inventory and pushing more advertisers into the same compliant auctions. Add in the fact that most healthcare search queries now carry local, mobile-first intent, and you get an auction environment where cost per click and the quality of that click both deserve equal scrutiny.
| Campaign Type | Avg CPC | IVT Rate | Avg CPA |
|---|---|---|---|
| Search | $6.775 | 4.39% | $55.20 |
| Display | $0.176 | 6.04% | — |
| Performance Max | $3.281 | 3.18% | $37.43 |
| Video | $44.610 | 0.40% | — |
| Demand Gen | $0.293 | 1.31% | — |
| Shopping | $1.184 | 3.97% | $20.82 |
Figures above are per Lunio's 2026 Healthcare / Pharma benchmark dataset, captured in monitor-only mode across tracked accounts as of September 2026. Healthcare search also skews heavily mobile, since most "near me" and urgent-care queries happen on a phone rather than a desktop. No Healthcare / Pharma-specific mobile versus desktop CPC split currently exists in any verifiable benchmark source, but mobile booking flows typically add friction that desktop sessions don't, which can inflate mobile CPA even when the mobile CPC itself looks cheaper. Treat any single blended CPC figure with that caveat in mind.
Additional Metrics: CTR, CVR, CPA/CPL & ROAS
Three additional metrics have verifiable data behind them for Healthcare / Pharma on Google Ads. A Healthcare / Pharma-specific ROAS figure for Google Ads doesn't exist in any benchmark source identified, largely because revenue attribution requires EMR or scheduling-system integration that most advertisers don't have, so it's left out rather than guessed.
| Metric | Average | Notes |
|---|---|---|
| CTR | 6.07% (LocaliQ, Oct 2024 to Sep 2025) | A healthy-looking CTR can include bot-driven clicks; Lunio's 4.39% Search IVT rate means a reported 5% CTR may be closer to 4.8% once invalid clicks are removed. |
| CVR | 13.48% (Lunio Search, 2026) | Reported CVR is computed on a denominator that includes invalid clicks that could never convert, so the genuine conversion rate on clean traffic is likely higher than this figure suggests. |
| CPA/CPL | $55.20 (Lunio Search, 2026) | Adjusted for the 4.39% Search IVT rate, the effective cost per genuine lead rises to roughly $57.73, since invalid clicks that never had a chance to convert are still part of the spend base. |
A Note on This Data
The campaign-type and country figures above come from Lunio's proprietary 2026 Healthcare / Pharma dataset, captured in monitor-only mode across tracked advertiser accounts. Sample sizes vary from five accounts for Search down to a single account for Video and Shopping, which are included as directional data points rather than statistical benchmarks. The absence of healthcare-specific CPM and ROAS figures reflects genuine gaps in published research, not an oversight, and is cross-referenced against the broader Lunio 2026 Global Invalid Traffic Report, which covers 2.7 billion clicks across 6 ad platforms from August 2024 to July 2025. Calculate how much you're losing →
Google Ads Benchmarks for Healthcare / Pharma by Campaign Type & Placement
Not every Google Ads campaign type carries the same invalid traffic risk, and for Healthcare / Pharma advertisers the gap between the cleanest and dirtiest format is wide enough to change budget allocation decisions. The pattern below uses Lunio's tracked account data where the sample supports it, and flags campaign types where results should be read as directional rather than definitive.
Search carries the highest and most reliable Healthcare / Pharma CPC in Lunio's dataset at $6.775, with a 4.39% IVT rate across five tracked accounts, the only campaign type here with a statistically robust sample. At that CPC, every invalid click costs $6.78, making Search the single most expensive place for IVT to hide in a Healthcare / Pharma account. Advertisers testing AI Max for Search should budget for more exposure, not less: AI Max increases IVT exposure by roughly 35% above the Search baseline, per Lunio's 2026 Global Invalid Traffic Report.
Display is the dirtiest campaign type in Lunio's Healthcare / Pharma sample at 6.04% IVT, based on a small two-account sample, even though its $0.176 CPC makes the per-click cost look negligible. The real risk isn't the wasted pennies, it's what those invalid clicks do downstream: Display is where Healthcare / Pharma advertisers build retargeting pools, and invalid sessions inflate those audiences with non-human signals that then receive budget across the rest of the funnel. See Lunio's analysis of invalid traffic inside Google Ads for more on how this compounds.
Performance Max sits in the middle at 3.18% IVT, based on three tracked accounts, with a $3.281 CPC, $37.43 CPA, and 8.76% CVR. Because PMax blends Search, Display, YouTube, Shopping, and Discover inventory into one automated campaign, a single blended IVT rate can mask a much higher rate on one surface and a much lower rate on another, and the advertiser has limited visibility into which placement is driving the contamination.
Lunio's single tracked Video account recorded a 0.40% IVT rate, but with a $44.610 CPC this is an outlier reflecting one advertiser's cost-per-conversion bidding model rather than a usable Healthcare / Pharma benchmark. It's worth noting that Google Video Partners inventory specifically carries a 20.62% platform-level IVT rate, a reminder that video IVT exposure can vary enormously depending on which YouTube placements an account actually buys.
Demand Gen is the cleanest multi-account campaign type in the dataset at 1.31% IVT, based on four tracked accounts, and a $0.293 CPC, making it a relatively low-risk format for Healthcare / Pharma advertisers testing visually rich, mid-funnel placements across YouTube, Gmail, and Discover.
Shopping shows a 3.97% IVT rate alongside a $1.184 CPC, $20.82 CPA, and 5.69% CVR, though this is a single-account data point most relevant to OTC health products, medical devices, or supplements rather than prescription pharma. Treat it as anecdotal context, not a benchmark to plan a budget against.
Google Ads Benchmarks for Healthcare / Pharma by Country & Region
| Country | Avg CPC | IVT Rate |
|---|---|---|
| United States | $3.450 | 2.78% |
| United Kingdom | $2.140 | 1.88% |
| Germany | $6.990 | 19.03% |
| France | $1.890 | 6.14% |
| Australia | $2.350 | 1.05% |
| Canada | $2.230 | 1.91% |
Germany is the standout double-risk market in Lunio's Healthcare / Pharma dataset: the highest CPC at $6.990 combined with a 19.03% IVT rate. At those figures, roughly $1.33 of every $6.99 German click goes to invalid traffic before any platform-native filter has a chance to act, nearly five times the US rate of 2.78% and more than ten times Australia's 1.05%. France sits at a moderate 6.14% IVT with a $1.890 CPC, while the UK, at 1.88% IVT and $2.140 CPC, and Australia emerge as the most efficient markets in the dataset, delivering the highest proportion of genuine clicks per dollar spent. Any Healthcare / Pharma advertiser with meaningful DACH spend should treat the German figure as an urgent finding worth investigating directly, and Lunio's ad fraud data by country provides further detail on how these patterns show up across other markets and verticals.
How Much of Your Google Ads Budget Is Being Wasted on Invalid Traffic?
Healthcare / Pharma is overwhelmingly a lead-gen vertical: appointment requests, consultation bookings, HCP registrations, and clinical trial screeners all rely on a form fill or a phone call, not a completed purchase. That structure matters because lead-gen campaigns carry a 32.07% higher IVT rate than transactional campaigns, per Lunio's 2026 Global Invalid Traffic Report, since a fake form submission is far easier to fabricate than a completed, payment-processed purchase.
Take a Healthcare / Pharma advertiser spending $1.5 million a year on Google Ads, split roughly 60% Search, 25% Performance Max, and 15% Display, Video, and Demand Gen combined. At Lunio's observed IVT rates, Search spend of $900,000 loses an estimated $39,510 to invalid traffic at 4.39%. PMax spend of $375,000 loses roughly $11,925 at 3.18%. The remaining $225,000 across Display, Video, and Demand Gen loses an estimated $9,000 at a blended rate near 4%. That's approximately $60,435 in direct annual waste, before accounting for the indirect cost of Smart Bidding learning from contaminated conversion signals.
This pattern isn't unique to Healthcare / Pharma. Culligan Harvey, a UK lead-gen advertiser running Google Search and Performance Max, cut invalid traffic by 54% after fake form fills and spam submissions were inflating lead volume without producing genuine demos, and saw its Lead to MQL conversion rate rise 10% as a result. The mechanism is the same one described above: invalid form fills register as legitimate non-converting signals, and Smart Bidding quietly optimises toward the wrong traffic until someone removes the noise.
Start your free 14-day traffic audit with Lunio →
Calculate Your Wasted Ad Spend
60 seconds, no signup. Built on Lunio's analysis of 2.7B+ ad clicks. Find out your industry's invalid traffic rate, your wasted spend, and the revenue you could recover.
from your business every year. That's $0 every month walking out the door — and another $0 every day you don't act.
Run a free 14-day audit on your live account and see your real numbers — broken down by campaign, keyword, geo and domain.
Calculations based on Lunio's Global Invalid Traffic Report 2026. Eight industries shown use Lunio-measured rates; additional industries use Lunio-methodology estimates calibrated against comparable verticals. Lost revenue applies Lunio's conservative 3:1 ROAS baseline — every $1 of wasted ad spend equals roughly $3 in missed revenue. Actual results vary by account.
Google Ads Benchmarks Are a Starting Point for Healthcare / Pharma, Not an Endpoint
Every benchmark on this page tells you what the market pays. None of them tell you, on their own, how much of that spend reaches a real patient, caregiver, or HCP rather than a bot that slipped past Google's native filters. That gap, measured across Search, Performance Max, Display, and six countries, is exactly what Lunio's detection layer surfaces for Healthcare / Pharma advertisers managing serious Google Ads budgets. Benchmarks tell you if your numbers look normal; an independent traffic audit tells you what's actually driving them.
Start your free 14-day traffic audit with Lunio →
FAQ
What is the average CPC for Healthcare / Pharma on Google Ads?
Lunio's 2026 Healthcare / Pharma benchmark data puts average Search CPC at $6.775 across tracked accounts, which sits at the high end of external ranges. For comparison, LocaliQ's October 2024 to September 2025 dataset of 3,542 US healthcare campaigns reports an overall search CPC of $5.64, with individual specialties ranging from roughly $2.29 for emergency medicine to $8.76 for orthodontics. The higher Lunio figure likely reflects a sample skewed toward larger-spend pharma and healthcare service advertisers bidding on high-intent terms.
What's a good CTR for Google Ads in Healthcare / Pharma, and when is a high CTR a warning sign?
LocaliQ reports an overall healthcare search CTR of 6.07% for the period October 2024 to September 2025, well above the frequently cited but outdated WordStream figure of 3.27% from 2017 to 2018. A CTR well above either benchmark isn't automatically good news: Lunio's data shows 4.39% of Healthcare / Pharma Search clicks are invalid even after clearing Google's own filters, so an unusually high CTR on a specific keyword or placement can indicate bot-driven clicks inflating the numbers rather than genuine patient or HCP interest.
How does invalid traffic affect my Google Ads benchmarks?
Invalid traffic includes both general invalid traffic, such as known bots and crawlers, and sophisticated invalid traffic, such as disguised bots or deliberate fraudulent clicks, and both inflate click counts without adding genuine conversions. Google's Ad Traffic Quality team uses automated filters, machine learning, and manual review to catch invalid activity; clicks caught before the billing cycle closes are removed automatically, while those caught after billing closes are returned only as a billing credit, never a cash refund, and by then may have already fed a contaminated signal into Smart Bidding. For Healthcare / Pharma specifically, this means published CPA and CVR benchmarks are computed on a traffic base that includes a measurable share of non-human activity.
How do Google Ads IVT rates differ between the US and Europe?
Lunio's Healthcare / Pharma dataset shows the US at a relatively moderate 2.78% IVT rate with a $3.450 CPC. Within Europe, the picture varies sharply: the UK sits at just 1.88% IVT, France at 6.14%, and Germany at 19.03%, the highest rate in the dataset, alongside the highest CPC at $6.990. That spread means a blanket "European average" is not useful for budget planning; Healthcare / Pharma advertisers with multi-market spend need to look at each country individually, particularly before committing budget to Germany.
Table of Contents
On average, 8.51% of your ad budget is wasted.
But that number can be much higher. Find out how much you're spending on bot traffic.
%20The%20Complete%202026%20Definition%2c%20Types%2c%20and%20Detection%20Guide.png?width=600&name=What%20Is%20Invalid%20Traffic%20(IVT)%20The%20Complete%202026%20Definition,%20Types,%20and%20Detection%20Guide.png)
